Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/201295
Title: | Association of anandamide and 2-Arachinodoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity |
Author: | Baenas, Isabel Miranda Olivos, Romina Granero, Roser Solé Morata, Neus Sánchez, Isabel Pastor, Antoni Pino Gutiérrez, Amparo Del Codina, Ester Tinahones, Francisco J. Fernández Formoso, Jose A. Vilarrasa, Nuria Guerrero Pérez, Fernando López Urdiales, Rafael Virgili, Núria Soriano Mas, Carles Jiménez-Murcia, Susana Torre Fornell, Rafael de la Fernández Aranda, Fernando |
Keywords: | Adults Pes corporal Trastorns de la conducta alimentària Adulthood Body weight Eating disorders |
Issue Date: | 1-Dec-2023 |
Publisher: | Cambridge University Press |
Abstract: | Background: Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) play a pivotal role in stimulating motivational behavior toward food and energy metabolism. Aberrant functioning of the endocannabinoid system has been observed in extreme weight conditions (EWCs), suggesting it may influence pathophysiology. Then, we aimed to analyze fasting AEA and 2-AG plasma concentrations among individuals with EWC (i.e., anorexia nervosa [AN] and obesity with and without eating disorders [EDs]) compared with healthy controls (HCs), and its association with clinical variables and body mass index (BMI). Methods: The sample included 113 adult women. Fifty-seven belonged to the obesity group, 37 without EDs (OB-ED) and 20 with ED (OB+ED classified within the binge spectrum disorders), 27 individuals from the AN group, and 29 from the HC group. Peripheral blood samples, several clinical variables, and BMI were evaluated. Results: Unlike 2-AG, AEA concentrations showed significant differences between groups (p < 0.001). Increased AEA was observed in the OB-ED and OB+ED compared with both HC and AN group, respectively. Likewise, AEA was differentially associated with emotional dysregulation, general psychopathology, food addiction, and BMI in all clinical groups. Conclusions: These results support the interaction between biological and clinical factors contributing to delineating vulnerability pathways in EWC that could help fit personalized therapeutic approaches. |
Note: | Reproducció del document publicat a: https://doi.org/10.1192/j.eurpsy.2023.2411 |
It is part of: | European Psychiatry, 2023, vol. 66, num. 1 |
URI: | http://hdl.handle.net/2445/201295 |
Related resource: | https://doi.org/10.1192/j.eurpsy.2023.2411 |
ISSN: | 0924-9338 |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
736949.pdf | 598.8 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License